@xconomy.com 4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com 5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@pmarca 8 years ago
RT @paul1kirby: Cracking account of CRISPR & the explosive potential for medicine, politics & business. "As big as the nuclear bomb" http://www.newyorker.com/magazine/2015/11/16/the-gene-hackers